Abstract:In silico immunogenicity risk assessment has been an important step in the development path for many biologic therapeutics, including monoclonal antibodies. Even if the source of a given biologic is 'fully human', T cell epitopes that are contained in the sequences of the biologic may activate the immune system, enabling the development of anti-drug antibodies that can reduce drug efficacy and may contribute to adverse events. Computational tools that identify T cell epitopes from primary amino acid sequences have been used to assess the immunogenic potential of therapeutic candidates for several decades. To facilitate larger scale analyses and accelerate preclinical immunogenicity risk assessment, our group developed an integrated web-based platform called ISPRI, (Immunogenicity Screening and Protein Re-engineering Interface) that provides hands-on access through a secure web-based interface for scientists working in large and mid-sized biotech companies in the US, Europe, and Japan. This toolkit has evolved and now contains an array of algorithms that can be used individually and/or consecutively for immunogenicity assessment and protein engineering. Most analyses start with the advanced epitope mapping tool (EpiMatrix), then proceed to identify epitope clusters using ClustiMer, and then use a tool called JanusMatrix to define whether any of the T cell epitope clusters may generate a regulatory T cell response which may diminish or eliminate anti-drug antibody formation. Candidates can be compared to similar products on a normalized immunogenicity scale. Should modifications to the biologic sequence be an option, a tool for moderating putative immunogenicity by editing T cell epitopes out of the sequence is available (OptiMatrix). Although this perspective discusses the in-silico immunogenicity risk assessment for monoclonal antibodies, bi-specifics, multi-specifics, and antibody-drug conjugates, the analysis of additional therapeutic modalities such as enzyme replacement proteins, blood factor proteins, CAR-T, gene therapy products, and peptide drugs is also made available on the ISPRI platform. ISPRI (Interactive Screening and Protein Reengineering Interface) : Integrated, cloud-based, comprehensive toolkit for Immunogenicity Risk Assessment. EpiMatrix Immunogenicity Score : Combined T effector and Treg Epitope Content per unit protein. Tregitopes : Treg Epitopes found in IgG Framework that have been shown to modulate antigen-specific effector T cell responses. ClustiMer : Tool for identifying epitope rich polypeptides from within a given protein sequence. JanusMatrix : Tool for Predicting Tolerance, Putative Treg Epitopes, and Anti-self-immune responses. OptiMatrix : Tool for modifying T cell epitope sequences to reduce (or enhance) MHC binding.

Immune Epitope Database Analysis Resource (Iedb-Ar)

The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design

EpiToolKit—a web-based workbench for vaccine design

Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies

PIRD: Pan Immune Repertoire Database

Improving B-cell Epitope Prediction and Its Application to Global Antibody-Antigen Docking.

Evaluation of Spatial Epitope Computational Tools Based on Experimentally-Confirmed Dataset for Protein Antigens

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

The Cancer Epitope Database and Analysis Resource (CEDAR)

IEAtlas: an atlas of HLA-presented immune epitopes derived from non-coding regions

IEPAPI: a Method for Immune Epitope Prediction by Incorporating Antigen Presentation and Immunogenicity

ICBcomb: a comprehensive expression database for immune checkpoint blockade combination therapy

Epitope Predictions Indicate The Presence Of Two Distinct Types Of Epitope-Antibody-Reactivities Determined By Epitope Profiling Of Intravenous Immunoglobulins

Epitope-Evaluator: An interactive web application to study predicted T-cell epitopes.

SEPPA 2.0--more refined server to predict spatial epitope considering species of immune host and subcellular localization of protein antigen.

The EMBL-EBI bioinformatics web and programmatic tools framework

BCEPS: A Web Server to Predict Linear B Cell Epitopes with Enhanced Immunogenicity and Cross-Reactivity

ICEberg 2.0: an updated database of bacterial integrative and conjugative elements

RAPID: A Rep-Seq Dataset Analysis Platform With an Integrated Antibody Database

DiscoTope-3.0: improved B-cell epitope prediction using inverse folding latent representations

SEPPA 3.0-enhanced spatial epitope prediction enabling glycoprotein antigens.